Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
thyroid eye disease
Pharma
Amgen lays out plan to boost sales of newly acquired Tepezza
Amgen has a plan to regain the sales momentum of newly acquired drug Tepezza, which was gained in the company's $27.8B buyout of Horizon Therapeutics.
Kevin Dunleavy
Oct 31, 2023 11:29am
Horizon plays 'pass the glass' in World Sight Day campaign
Sep 15, 2022 8:25am
Horizon's eye disease awareness juggernaut continues apace
Jul 15, 2022 10:45am
'Dear TED': Horizon asks patients to write to their eye disease
May 12, 2022 11:50am
Horizon and Olympian raise awareness for Graves' and TED link
Jul 12, 2021 9:35am
Horizon is paying $65M to pick up a factory all its own
Jun 23, 2021 7:15am